跳至主要内容
临床试验/ACTRN12610000016033
ACTRN12610000016033已完成4 期

Randomized trial comparing valacyclovir versus valganciclovir prophylaxis of cytomegalovirus infection in renal transplant recipients

Tomas Reischig, M.D., Ph.D.0 个研究点目标入组 114 人开始时间: 2007年9月26日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Recipients of transplant from deceased or living donor, known donor (D) and recipient (R) CMV serology before transplantation of D+/R- or D+/R+ or D-/R+, provided informed consent

排除标准

  • Unknown or D-/R- CMV serology prior to transplantation, systemic antiviral drug intake within 2 weeks before transplantation except for hepatitis B therapy (lamivudine, adefovir, entecavir), active viral infection at the time of transplantation (except for hepatitis B or C), significant leukopenia or thrombocytopenia, participation in another clinical trial, known allergy to (val)acyclovir or (val)ganciclovir, inability to provide informed concent

研究者

发起方
Tomas Reischig, M.D., Ph.D.

相似试验

已完成
不适用
A randomized non-inferiority trial of valganciclovir versus intravenous ganciclovir as preemptive therapy for cytomegalovirus infection in living donor liver transplantation.cytomegalovirus infection after living donor liver transplantation
JPRN-C000000295Artificial Organ and Transplantation Division, Tokyo University Hospital140
已完成
不适用
Double-blind Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with InfluenzaInfluenza
JPRN-UMIN000034870Kitano Hospital, Tazuke Kofukai Medical Research Institute. Department of Pediatrics40
已完成
不适用
Randomised controlled trial comparing voltarol and paracetamol analgesia following oocyte collection in in vitro fertilisation (IVF) patients.
ISRCTN73847754Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
已完成
4 期
Preemptive therapy vs valacyclovir prophylaxis for cytomegalovirus (CMV) disease after renal transplantatioCytomegalovirus disease in renal transplant recipientsInfection - Studies of infection and infectious agentsRenal and Urogenital - Kidney disease
ACTRN12610000015044Tomas Reischig, M.D., Ph.D.60
招募中
1 期
Clinical trial (study) comparing the efficacy and safety of valacyclovir used in the prevention and treatment of primary cytomegalovirus (CMV) infection in pregnant women depending on the used drug dose.primary cytomegalovirus (CMV) infectionMedDRA version: 20.0Level: LLTClassification code: 10009703Term: CMV infection Class: 10021881
CTIS2023-508643-46-00Instytut Matki I Dziecka200